These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20828636)

  • 1. A web-based medical safety reporting system for a large multicenter clinical trial: the ALIAS experience.
    Zhao W; Waldman BD; Dillon C; Pauls K; Kim J; Patterson L; Ginsberg MD; Hill MD; Palesch Y
    Contemp Clin Trials; 2010 Nov; 31(6):536-43. PubMed ID: 20828636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression.
    Durkalski V; Wenle Zhao ; Dillon C; Kim J
    Clin Trials; 2010 Apr; 7(2):174-82. PubMed ID: 20083496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system.
    Zhao W; Pauls K
    Clin Trials; 2016 Apr; 13(2):223-33. PubMed ID: 26464429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The automation of clinical trial serious adverse event reporting workflow.
    London JW; Smalley KJ; Conner K; Smith JB
    Clin Trials; 2009 Oct; 6(5):446-54. PubMed ID: 19737847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form.
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):738. PubMed ID: 28704349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting.
    Linder JA; Haas JS; Iyer A; Labuzetta MA; Ibara M; Celeste M; Getty G; Bates DW
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1211-5. PubMed ID: 21155192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated summaries of serious adverse events in the hepatitis C antiviral long-term treatment against cirrhosis trial.
    Bell MC; Robuck PR; Wright EC; Mihova MS; Hofmann C; De Santo JL; Milstein SL; Richtmyer PA; Shelton JL; Cormier M; King DL; Park CJ; Molchen WA; Park Y; Kelley M
    Clin Trials; 2009 Dec; 6(6):618-27. PubMed ID: 19889888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.
    Moore TJ; Furberg CD; Mattison DR; Cohen MR
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):713-8. PubMed ID: 26861066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electronic regulatory document management system for a clinical trial network.
    Zhao W; Durkalski V; Pauls K; Dillon C; Kim J; Kolk D; Silbergleit R; Stevenson V; Palesch Y
    Contemp Clin Trials; 2010 Jan; 31(1):27-33. PubMed ID: 19782156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols.
    Ebile AW; Ateudjieu J; Yakum MN; Djuidje MN; Watcho P
    BMC Med Ethics; 2015 Sep; 16(1):67. PubMed ID: 26420169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Internet and drug safety: what are the implications for pharmacovigilance?
    Cobert B; Silvey J
    Drug Saf; 1999 Feb; 20(2):95-107. PubMed ID: 10082068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.
    Perez R; Archdeacon P; Roach N; Goodwin R; Jarow J; Stuccio N; Forrest A
    Clin Trials; 2017 Jun; 14(3):225-233. PubMed ID: 28345368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision support environment for medical product safety surveillance.
    Botsis T; Jankosky C; Arya D; Kreimeyer K; Foster M; Pandey A; Wang W; Zhang G; Forshee R; Goud R; Menschik D; Walderhaug M; Woo EJ; Scott J
    J Biomed Inform; 2016 Dec; 64():354-362. PubMed ID: 27477839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of adverse events to MedWatch.
    Piazza-Hepp TD; Kennedy DL
    Am J Health Syst Pharm; 1995 Jul; 52(13):1436-9. PubMed ID: 7671043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
    Muñoz MA; Delcher C; Dal Pan GJ; Kortepeter CM; Wu E; Wei YJ; Xiao H; Winterstein AG
    Pharmacotherapy; 2019 Nov; 39(11):1042-1052. PubMed ID: 31479525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data and safety monitoring in social behavioral intervention trials: the REACH II experience.
    Czaja SJ; Schulz R; Belle SH; Burgio LD; Armstrong N; Gitlin LN; Coon DW; Martindale-Adams J; Klinger J; Stahl SM
    Clin Trials; 2006; 3(2):107-18. PubMed ID: 16773953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.